Your browser doesn't support javascript.
loading
Use of a botulinum toxin A in dentistry and oral and maxillofacial surgery
Journal of Dental Anesthesia and Pain Medicine ; : 151-157, 2016.
Article in English | WPRIM | ID: wpr-217988
ABSTRACT
Botulinum toxin (BT) was the first toxin to be used in the history of human medicine. Among the eight known serotypes of this toxin, those currently used in medicine are types A and B. This review article mainly discusses BT type A (BTA) because it is usually used in dentistry including dental anesthesiology and oral and maxillofacial surgery. BTA has been used mainly in the treatment of temporomandibular joint disorder (TMD) and hypertrophy and hyperactivity of the masticatory muscles, along with being a therapeutic option to relieve pain and help in functional recovery from dental and oral and maxillofacial surgery. However, it is currently used broadly for cosmetic purposes such as reducing facial wrinkles and asymmetry. Although the therapeutic effect of BTA is temporary and relatively safe, it is essential to have knowledge about related anatomy, as well as the systemic and local adverse effects of medications that are applied to the face.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Surgery, Oral / Botulinum Toxins / Temporomandibular Joint Disorders / Dentistry / Serogroup / Oral and Maxillofacial Surgeons / Hypertrophy / Anesthesiology / Masticatory Muscles Limits: Humans Language: English Journal: Journal of Dental Anesthesia and Pain Medicine Year: 2016 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Surgery, Oral / Botulinum Toxins / Temporomandibular Joint Disorders / Dentistry / Serogroup / Oral and Maxillofacial Surgeons / Hypertrophy / Anesthesiology / Masticatory Muscles Limits: Humans Language: English Journal: Journal of Dental Anesthesia and Pain Medicine Year: 2016 Type: Article